Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Heart Failure × Pyruvic Acid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 4 Warts 1 Metabolic Syndrome 1 Heart Failure 1 Cardiovascular Diseases 1

Interventions

Echocardiography 4 Standard of Care 3 Exercise 3 Electrocardiography 3 sacubitril and valsartan sodium hydrate drug combination 2 Surveys and Questionnaires 2 Spironolactone 2 Nutrition Assessment 2 Ivabradine 2 Carvedilol 2 Blood Specimen Collection 2 Atorvastatin 2 ziprasidone 1 pertuzumab 1 pegfilgrastim 1 nicotinamide-beta-riboside 1 empagliflozin 1 dapagliflozin 1 candesartan 1 Zolpidem 1 Watchful Waiting 1 Warfarin 1 Vincristine 1 Vecuronium Bromide 1 Vascular Stiffness 1 Vancomycin 1 Valsartan 1 Trastuzumab 1 Tranexamic Acid 1 Tobramycin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06645691 2024-12-06

POLARIC-13

National Heart Centre Singapore

Phase 2 Recruiting

Cardiovascular Diseases, Heart Failure, Metabolic Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡